0001209191-23-016739.txt : 20230307 0001209191-23-016739.hdr.sgml : 20230307 20230307162438 ACCESSION NUMBER: 0001209191-23-016739 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230303 FILED AS OF DATE: 20230307 DATE AS OF CHANGE: 20230307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shabbir Anik CENTRAL INDEX KEY: 0001751728 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38662 FILM NUMBER: 23712942 BUSINESS ADDRESS: STREET 1: 310 UTAH AVE, STE. 150 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-392-8412 MAIL ADDRESS: STREET 1: 310 UTAH AVE, STE. 150 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUTRO BIOPHARMA, INC. CENTRAL INDEX KEY: 0001382101 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 452441988 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-392-8412 MAIL ADDRESS: STREET 1: 111 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: SUTRO BIOPHARMA INC DATE OF NAME CHANGE: 20061127 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-03 0 0001382101 SUTRO BIOPHARMA, INC. STRO 0001751728 Shabbir Anik C/O SUTRO BIOPHARMA, INC 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Technical Ops. Officer Common Stock 2023-03-03 4 M 0 7875 A 38299 D Common Stock 2023-03-03 4 M 0 8750 A 47049 D Common Stock 2023-03-03 4 F 0 6222 5.79 D 40827 D Restricted Stock Unit (RSU) 2023-03-03 4 A 0 40000 0.00 A 2025-03-01 Common Stock 40000 40000 D Restricted Stock Unit (RSU) 2023-03-03 4 M 0 7875 0.00 D 2026-03-04 Common Stock 7875 23625 D Restricted Stock Unit (RSU) 2023-03-03 4 M 0 8750 0.00 D 2025-03-05 Common Stock 8750 17500 D Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. The RSUs vest as to 1/2 of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date. The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date. The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date. /s/ Edward C. Albini as attorney-in-fact for Shabbir Anik 2023-03-07